HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, Volume 2, February 2016 Biomedical Research Governance       » Tissue banking in Singapore — An Evolving Enterprise       » China Recognizes Prominent Scientists and Stresses on Innovation       » NUS Researchers Uncover Potent Parasite-killing Mechanism of Nobel Prize-Winning Anti-Malarial Drug       » A New Water Robot "Born" to Detect Water Quality       » Probing the Mystery of How Cancer Cells Die       » Researchers Find Link between Processed Foods and Autoimmune Diseases       » Unravelling the Genetics of Pregnancy and Heart Failure      
EYE ON CHINA
Taiwan government to encourage formation of smaller biotech funds
The scientific and technology task force of the Executive Yuan (the Cabinet) has approved the revised “action program for the takeoff of the Taiwanese biotech industry,” according to which the government will encourage the formation of medium and small biotech venture capital funds ranging in scale from NT$500 million to NT$1bilion and the national development fund will invest in individual projects directly.

Chang Shan-cheng, noted that the government will push the establishment of big biotech venture capital funds two to three years later, after the achievement of several successful cases and the formation of confidence in the private sector. Then the national development fund will contribute to the big biotech venture capital fund at the maximum share of 40%, or the ceiling of NT$2 billion.

Meanwhile, in addition to the two major items of pharmaceuticals and medical devices for the development of the biotech industry, the government will add the item of medical management to the program, aiming to achieve the export of medical-management expertise. The revised program calls for the investment of NT$300 million in three years in the cultivation of 300 high-caliber talents needed by the industry. The program expects to cultivate 100 post-doctoral researchers and have them receive training at corporate bodies or schools. The government will subsidize those units by giving them NT$1 million per researcher annually.

The “action program for the takeoff of the Taiwanese biotech industry” originally envisioned the establishment of NT$60 billion big biotech venture capital fund, to be contributed by the national development fund and the private sector jointly. The plan, however, was aborted after Yue-Teh Jang, general partner of Vertical Group, the largest venture capital fund for medical devices in the U.S., failed to raise funds for Taiwan Medtech Fund in mid-June this year.

Chang Shan-cheng pointed out that biotech venture capital funds will be funded mainly by the private sector and the national development fund will play a supporting role. For common biotech venture capital funds, the national development fund will invest no more than 30% of the total amount; it will also invest less than NT$1 billion in an individual case directly.

For pharmaceuticals, the program calls for pushing cross-Taiwan Strait cooperation for clinical test and assisting domestic firms to team up for tapping the mainland Chinese market.

Click here for the complete issue.

NEWS CRUNCH  
news Singapore Researchers Develop World'S First High-Throughput Imaging Platform for Predicting Kidney Toxicity
news Collaboration is Cure for Better Global Health Outcomes, UK-India Experts Say
news EmTech Asia Opens: Features 50 speakers on innovation and emerging technologies
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Primates in Biomedical Research
COLUMNS  
\
APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Cancerology / Oncology
May:
Guest Editorial - Antibody Informatics In Japan
June:
Medical Devices and Technology
July:
Water Technology
August:
Occupational Health
September:
Olympics: Evolution of Sports
October:
Respiratory: Seasonal flu viruses
November:
Tobacco Smoking
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim/td>
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy